Drug treatment for melanoma: progress, but who pays?

Med J Aust. 2012 Nov 5;197(9):491. doi: 10.5694/mja12.11314.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Drug Costs*
  • Financing, Government*
  • Health Policy / economics*
  • Humans
  • Indoles / therapeutic use*
  • Melanoma / drug therapy*
  • Sulfonamides / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Indoles
  • Sulfonamides